RCUS NYSE
Arcus Biosciences, Inc.
1W: -2.0%
1M: -18.1%
3M: -18.4%
YTD: +5.0%
1Y: +81.5%
3Y: +30.4%
5Y: -32.0%
$24.44
-0.79 (-3.13%)
Weekly Expected Move ±7.0%
$21
$23
$24
$26
$28
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$117M
Revenue
-55.3% YoY
$-452M
Net Income
-47.7% YoY
$-475M
Free Cash Flow
-38.9% YoY
100.0%
Gross Margin
-234.1%
Op. Margin
-222.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-89.2%
ROA-45.2%
ROIC309.6%
Valuation
P/E-6.2
P/B6.6
EV/EBITDA-7.9
Leverage
Debt/Equity0.25
Current Ratio3.82
Interest Cov.-18.7x
Quality Scores
Piotroski F0/9
Altman Z1.81
Beneish M2.40